Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity.

MLA

Xian, Zhong, et al. “Differences in P38-STAT3-S100A11 Signaling after the Administration of Aristolochic Acid I and IVa May Account for the Disparity in Their Nephrotoxicity.” Phytomedicine, vol. 114, June 2023, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.phymed.2023.154815.

APA

Xian, Z., Tian, J., Zhao, Y., Yi, Y., Li, C., Han, J., Zhang, Y., Wang, Y., Wang, L., Liu, S., Pan, C., Liu, C., Wang, D., Meng, J., Tang, X., Wang, F., & Liang, A. (2023). Differences in p38-STAT3-S100A11 signaling after the administration of aristolochic acid I and IVa may account for the disparity in their nephrotoxicity. Phytomedicine, 114, N.PAG. https://doi.org/10.1016/j.phymed.2023.154815

Chicago

Xian, Zhong, Jingzhuo Tian, Yong Zhao, Yan Yi, Chunying Li, Jiayin Han, Yushi Zhang, et al. 2023. “Differences in P38-STAT3-S100A11 Signaling after the Administration of Aristolochic Acid I and IVa May Account for the Disparity in Their Nephrotoxicity.” Phytomedicine 114 (June): N.PAG. doi:10.1016/j.phymed.2023.154815.